$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
肉瘤新药他泽司他用法是怎样的?他泽司他国内上市了吗?
2025-10-19 11:44:20
Check Details
他泽司他在河南哪里买的到?肉瘤新药他泽司他效果咋样?
2025-10-19 11:44:20
Check Details
肉瘤新药他泽司他详细介绍!
2025-10-19 11:44:20
Check Details
肉瘤新药-他泽司他(Tazemetostat)
2025-10-19 11:44:20
Check Details
他泽司他治疗上皮样肉瘤的效果怎么样?
2025-10-19 11:44:20
Check Details
肉瘤新药他泽司他获批上市!
2025-10-19 11:44:20
Check Details
他泽司他治疗肉瘤的效果和副作用是什么?
2025-10-19 11:44:20
Check Details
他泽司他可以用医保报销吗?治疗期间需要注意什么?
2025-10-19 11:44:20
Check Details
他泽司他(Tazemetostat)美国获批治疗上皮样肉瘤(ES)
2025-10-19 11:44:20
Check Details
【用药科普】他泽司他的使用方法及副作用
2025-10-19 11:44:20
Check Details
2023CSCO大会指南更新——小圆细胞肉瘤部分更新亮点
2025-10-19 11:44:20
Check Details
2023指南出炉!软骨肉瘤治疗药物汇总
2025-10-19 11:44:20
Check Details
1
2
...
6
7
8
9
10
11
12
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
2
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
3
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
4
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
5
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
6
Adagrasib Medication Management Guide for Special Populations
7
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
8
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
9
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
10
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer